Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001230569 | SCV001403053 | pathogenic | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2019-10-26 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with RTEL1-related conditions. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in RTEL1 are known to be pathogenic (PMID: 23453664, 23959892, 25607374). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln1057*) in the RTEL1 gene. It is expected to result in an absent or disrupted protein product. |
Gene |
RCV003153953 | SCV003842434 | likely pathogenic | not provided | 2023-03-12 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25607374, 23453664, 23959892) |
Baylor Genetics | RCV003469409 | SCV004209782 | likely pathogenic | Dyskeratosis congenita, autosomal recessive 5 | 2023-07-24 | criteria provided, single submitter | clinical testing |